Quarterly Results • Search Archive

OneSource Specialty Pharma Limited
Results, Financials & Updates

Follow OneSource Specialty Pharma Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

OneSource Specialty Pharma Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: ONESOURCE
Revenue from operations₹449.02 CrReported in the latest covered quarter
Profit after tax₹25.00 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

OneSource Specialty Pharma Limited operates as a pure-play specialty pharmaceutical contract development and manufacturing organization (CDMO), providing development and manufacturing solutions across complex pharmaceutical products. The company's core offerings span diverse high-barrier modalities including biologics, drug-device combinations (DDCs such as GLP-1 pens), sterile injectables, and soft gelatin capsules.

← All quarterly results

Quarter history

OneSource Specialty Pharma Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹449.02 Cr · PAT ₹25.00 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.